Abstract
The objective of this study was to evaluate immune cytokine expression in cerebrospinal fluid (CSF) of patients with human immunodeficiency virus-1 (HIV-1)-associated dementia (HAD) using a novel cytokine array assay. HIV-1 induces a condition resembling classical subcortical dementia, known as HAD. The immune mechanisms contributing to HAD have not been elucidated. Cytokine expression in CSF was determined by solid-phase protein array in 33 neurologically asymptomatic HIV-positive male patients and were compared to levels in non-HIV controls and patients with HAD. Neurological examinations and lumbar and venous punctures were conducted in all patients and controls. Interleukin (IL)-1, IL-4, and IL-10, were up-regulated in all treated acquired immunodeficiency syndrome (AIDS) patients independent of neurological status compared to controls. In contrast, interferon gamma (IFN-γ), IL-1α, IL-15, and tumor necrosis factor alpha (TNF-α) were highly expressed in patients with HAD compared to undemented HIV-positive patients. These results show that solid-phase protein array can detect immunological changes in patients infected with HIV. Cytokine expression levels differ in different disease stages and in patients on different treatment paradigms. Pending further validation on a larger number of patients, this method may be a useful tool in CSF diagnostics and the longitudinal evaluation of patient with HAD.
This is a preview of subscription content, log in via an institution to check access.
Similar content being viewed by others
References
Antinori A, Arendt G, Becker JT, Brew BJ, Byrd DA, Cherner M, Clifford DB, Cinque P, Epstein LG, Goodkin K, Gisslen M, Grant I, Heaton RK, Joseph J, Marder K, Marra CM, McArthur JC, Nunn M, Price RW, Pulliam L, Robertson KR, Sacktor N, Valcour V, Wojna VE (2007). Updated research nosology for HIV-associated neurocognitive disorders. Neurology 69: 1789–1799.
Aquaro S, Ronga L, Pollicita M, Antinori A, Ranazzi A, Perno CF (2005). Human immunodeficiency virus infection and acquired immunodeficiency syndrome dementia complex: role of cells of monocyte-macrophage lineage. J NeuroVirol 11(Suppl 3): 58–66.
Arendt G, Hefter H, Hilperath F, von Giesen HJ, Strohmeyer G, Freund HJ (1994). Motor analysis predicts progression in HIV-associated brain disease. J Neurol Sci 123: 180–185.
Arendt G, Nolting T, Frisch C, Husstedt IW, Gregor N, Koutsilieri E, Maschke M, Angerer A, Obermann M, Neuen-Jacob E, Adams O, Loeffert S, Riederer P, ter Meulen V, Sopper S (2007). Intrathecal viral replication and cerebral deficits in different stages of human immunodeficiency virus disease. J NeuroVirol 13: 225–232.
Arendt G, von Giesen HJ (2002). Human immunodeficiency virus dementia: evidence of a subcortical process from studies of fine finger movements. J NeuroVirol 8(Suppl 2): 27–32.
Bangs SC, McMichael AJ, Xu XN (2006). Bystander T cell activation—implications for HIV infection and other diseases. Trends Immunol 27: 518–524.
Buch S, Pinson D, King CL, Raghavan R, Hou Y, Li Z, Adany I, Hicks A, Villinger F, Kumar A, Narayan O (2001). Inhibitory and enhancing effects of IFN-gamma and IL-4 on SHIV(KU) replication in rhesus macaque macrophages: correlation between Th2 cytokines and productive infection in tissue macrophages during late-stage infection. Cytokine 13: 295–304.
Clerici M, Shearer GM (1993). A TH1→TH2 switch is a critical step in the etiology of HIV infection. Immunol Today 14: 107–111.
Cysique LA, Maruff P, Brew BJ (2004). Prevalence and pattern of neuropsychological impairment in human immunodeficiency virus-infected/acquired immunodeficiency syndrome (HIV/AIDS) patients across pre- and post-highly active antiretroviral therapy eras: a combined study of two cohorts. J NeuroVirol 10: 350–357.
Dhar A, Gardner J, Borgmann K, Wu L, Ghorpade A (2006). Novel role of TGF-beta in differential astrocyte-TIMP-1 regulation: implications for HIV-1-dementia and neuroinflammation. J Neurosci Res 83: 1271–1280.
Ehl S, Hombach J, Aichele P, Hengartner H, Zinkernagel RM (1997). Bystander activation of cytotoxic T cells: studies on the mechanism and evaluation of in vivo significance in a transgenic mouse model. J Exp Med 185: 1241–1251.
Faller EM, McVey MJ, Kakal JA, MacPherson PA (2006). Interleukin-7 receptor expression on CD8 T-cells is downregulated by the HIV Tat protein. J Acquir Immune Defic Syndr 43: 257–269.
Galli G, Annunziato F, Cosmi L, Manetti R, Maggi E, Romagnani S (2001). Th1 and th2 responses, HIV-1 coreceptors, and HIV-1 infection. J Biol Regul Homeost Agents 15: 308–313.
Gallo P, Frei K, Rordorf C, Lazdins J, Tavolato B, Fontana A (1989). Human immunodeficiency virus type 1 (HIV-1) infection of the central nervous system: an evaluation of cytokines in cerebrospinal fluid. J Neuroimmunol 23: 109–116.
Gallo P, Sivieri S, Rinaldi L, Yan XB, Lolli F, De Rossi A, Tavolato B (1994). Intrathecal synthesis of interleukin-10 (IL-10) in viral and inflammatory diseases of the central nervous system. J Neurol Sci 126: 49–53.
Garin A, Tarantino N, Faure S, Daoudi M, Lecureuil C, Bourdais A, Debre P, Deterre P, Combadiere C (2003). Two novel fully functional isoforms of CX3CR1 are potent HIV coreceptors. J Immunol 171: 5305–5312.
Hammer SM, Saag MS, Schechter M, Montaner JS, Schooley RT, Jacobsen DM, Thompson MA, Carpenter CC, Fischl MA, Gazzard BG, Gatell JM, Hirsch MS, Katzenstein DA, Richman DD, Vella S, Yeni PG, Volberding PA (2006). Treatment for adult HIV infection: 2006 recommendations of the International AIDS Society-USA panel. JAMA 296: 827–843.
Heeney JL, Plotkin SA (2006). Immunological correlates of protection from HIV infection and disease. Nat Immunol 7: 1281–1284.
Kaul M, Lipton SA (2006). Mechanisms of neuronal injury and death in HIV-1 associated dementia. Curr HIV Res 4: 307–318.
Killebrew DA, Troelstrup D, Valcour V, Williams A, Aguon J, Sapalo D, Shikuma C, Ratto-Kim S, Shiramizu B (2005). Discordant plasma and cerebral spinal fluid cytokines/chemokines in relation to HIV-1-associated dementia. Cell Mol Biol (Noisy-le-grand) 51(Suppl): OL745-OL754.
Lane BR, Strieter RM, Coffey MJ, Markovitz DM (2001). Human immunodeficiency virus type 1 (HIV-1)-induced GRO-alpha production stimulates HIV-1 replication in macrophages and T lymphocytes. J Virol 75: 5812–5822.
Lojek E, Bornstein RA (2005). The stability of neurocognitive patterns in HIV infected men: classification considerations. J Clin Exp Neuropsychol 27: 665–682.
Malaspina A, Moir S, Ho J, Wang W, Howell ML, O’Shea MA, Roby GA, Rehm CA, Mican JM, Chun TW, Fauci AS (2006). Appearance of immature/transitional B cells in HIV-infected individuals with advanced disease: correlation with increased IL-7. Proc Natl Acad Sci U S A 103: 2262–227.
Marchetti G, Gori A, Casabianca A, Magnani M, Franzetti F, Clerici M, Perno CF, Monforte A, Galli M, Meroni L (2006). Comparative analysis of T-cell turnover and homeostatic parameters in HIV-infected patients with discordant immune-virological responses to HAART. AIDS 20: 1727–1736.
McArthur JC (2004). HIV dementia: an evolving disease. J Neuroimmunol 157: 3–10.
McArthur JC, Brew BJ, Nath A (2005). Neurological complications of HIV infection. Lancet Neurol 4: 543–555.
McArthur JC, Haughey N, Gartner S, Conant K, Pardo C, Nath A, Sacktor N (2003). Human immunodeficiency virus-associated dementia: an evolving disease. J NeuroVirol 9: 205–221.
Navia BA, Rostasy K (2005). The AIDS dementia complex: clinical and basic neuroscience with implications for novel molecular therapies. Neurotox Res 8: 3–24.
Nielsen UB, Geierstanger BH (2004). Multiplexed sandwich assays in microarray format. J Immunol Methods 290: 107–120.
Nolting T, Arendt G (2008). Cytokine findings in the CSF of HIV-positive patients. Future HIV Therapy 2: 59–67.
Polman CH, O’Connor PW, Havrdova E, Hutchinson M, Kappos L, Miller DH, Phillips JT, Lublin FD, Giovannoni G, Wajgt A, Toal M, Lynn F, Panzara MA, Sandrock AW (2006). A randomized, placebo-controlled trial of natalizumab for relapsing multiple sclerosis. N Engl J Med 354: 899–910.
Romagnani S (2006). Regulation of the T cell response. Clin Exp Allergy 36: 1357–1366.
Rouse BT, Sarangi PP, Suvas S (2006). Regulatory T cells in virus infections. Immunol Rev 212: 272–286.
Rudick RA, Stuart WH, Calabresi PA, Confavreux C, Galetta SL, Radue EW, Lublin FD, Weinstock-Guttman B, Wynn DR, Lynn F, Panzara MA, Sandrock AW (2006). Natalizumab plus interferon beta-1a for relapsing multiple sclerosis. N Engl J Med 354: 911–923.
Schutzer SE, Brunner M, Fillit HM, Berger JR (2003). Autoimmune markers in HIV-associated dementia. J Neuroimmunol 138: 156–161.
Tong N, Perry SW, Zhang Q, James HJ, Guo H, Brooks A, Bal H, Kinnear SA, Fine S, Epstein LG, Dairaghi D, Schall TJ, Gendelman HE, Dewhurst S, Sharer LR, Gelbard HA (2000). Neuronal fractalkine expression in HIV-1 encephalitis: roles for macrophage recruitment and neuroprotection in the central nervous system. J Immunol 164: 1333–1339.
Valcour V, Shikuma C, Shiramizu B, Watters M, Poff P, Selnes O, Holck P, Grove J, Sacktor N (2004). Higher frequency of dementia in older HIV-1 individuals: the Hawaii Aging with HIV-1 Cohort. Neurology 63: 822–827.
Villard J, Dayer-Pastore F, Hamacher J, Aubert JD, Schlegel-Haueter S, Nicod LP (1995). GRO alpha and interleukin-8 in Pneumocystis carinii or bacterial pneumonia and adult respiratory distress syndrome. Am J Respir Crit Care Med 152: 1549–1554.
Wahl SM, Allen JB, McCartney-Francis N, Morganti-Kossmann MC, Kossmann T, Ellingsworth L, Mai UE, Mergenhagen SE, Orenstein JM (1991). Macrophage- and astrocyte-derived transforming growth factor beta as a mediator of central nervous system dysfunction in acquired immune deficiency syndrome. J Exp Med 173: 981–991.
Yonekawa K, Harlan JM (2005). Targeting leukocyte integrins in human diseases. J Leukoc Biol 77: 129–140.
Author information
Authors and Affiliations
Consortia
Corresponding author
Additional information
This work was the supported by the German “Bundesministerium fuer Bildung und Forschung” (Federal Ministry of Education and Research; BMBF); grant 01KI0211.
Rights and permissions
About this article
Cite this article
Nolting, T., Lindecke, A., Koutsilieri, E. et al. Measurement of soluble inflammatory mediators in cerebrospinal fluid of human immunodeficiency virus-positive patients at distinct stages of infection by solid-phase protein array. Journal of NeuroVirology 15, 390–400 (2009). https://doi.org/10.3109/13550280903350192
Received:
Revised:
Accepted:
Issue Date:
DOI: https://doi.org/10.3109/13550280903350192